← Search

Data · dataset · 2026

Intrascleral implants for posterior segment drug delivery

Listed in ZivaHub and Deakin Research Online and DMU Figshare — shown once because both records carry DOI 10.17034/32805866.v1

Age-related macular degeneration (AMO) and diabetic retinopathy (DR) are chronic ocular diseases that can cause vision loss, primarily affecting the elderly and diabetic populations worldwide.

Description

In these conditions, abnormal blood vessels grow at the back of the eye, damaging the posterior segment. These immature vessels leak blood into the retina, exacerbating the condition.

Clinical biomarkers for these disorders include elevated levels of inflammatory markers and growth factors like vascular endothelial growth factor (VEGF), indicating chronic inflammation and pathologic angiogenesis. <br><br>Current treatments involve frequent intravitreal injections of anti-VEGF antibodies directly into vitreous humor. While achieving high drug concentrations with fewer side effects than systemic delivery, these injections carry risks of serious eye infections, retinal detachment, and intravitreal hemorrhage. <br><br>This thesis hypothesises that episcleral and intrascleral routes offer minimally invasive methods for delivering sustained-release formulations to the posterior segment.

Read the rest (3 more)

Two novel drug delivery platforms were developed and characterized: poly (glycerol sebacate):gelatin (PGS:gelatin) electrospun inserts loaded with sunitinib, and hydroxypropyl-β-cyclodextrin (HPβCD)-based electrospun inserts loaded with fenofibrate. <br>The PGS: gelatin system was optimized for polymer ratio, with the 3:2 PGS:gelatin ratio showing the most favourable release profile over an eight-day period. Both episcleral and intrascleral applications were were investigated, with episcleral administration showing higher initial drug permeation (12.5% across sclera within 24 h) compared to intrascleral delivery (10%), while intrascleral implants provided more uniform daily drug release.

The formation of inclusion complexes between fenofibrate and HPβCD, confirmed through multiple analytical techniques, significantly enhanced drug solubility in the second system. This polymer-free electrospun system maintained therapeutic activity while improving delivery efficiency, with higher drug loadings showing more sustained release profiles.<br><br><div>In vitro biocompatibility studies on ARPE-19 cells and the Hen's egg test-chorioallantoic membrane (HET-CAM) assay demonstrated both systems' safety for ocular application, with no signs of blood vessel rupture, hemorrhage, or coagulation.

Cell viability remained above 85% across all formulations tested. Both delivery systems demonstrated significant anti-angiogenic effects in multiple models, including wound healing assays, fibrin bead assays, and Ex vivo choroidal sprouting assays. The sunitinib-loaded system showed superior performance to clinically established VEGF inhibitors in the fibrin bead assay, in ex vivo models.</div><div><br></div><div>This research demonstrates the potential of episcleral and intrascleral routes for minimally invasive depot forming drug delivery systems, offering the potential for less frequent administration in the long-term manaoement of chronic posterior seoment ocular diseases like AMO and diabetic retinopathv.</div><div><br></div><div><i>Thesis is embargoed until 31 July 2028</i>.</div>

Links

Where it is published

Catalogue records · 1

Topics

Provenance · 3 source records, 8 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/3280586613 d agoJSON v1
Deakin Research Onlineoai:figshare.com:article/3280586613 d agoJSON v1
DMU Figshareoai:figshare.com:article/3280586613 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:earth-environmentalmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:earth-environmentalmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
license_textsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title